Arrowhead Pharmaceuticals Inc’s recently made public that its Chief Executive Officer Anzalone Christopher Richard unloaded Company’s shares for reported $0.77 million on Mar 13 ’25. In the deal valued at $15.07 per share,51,425 shares were sold. As a result of this transaction, Anzalone Christopher Richard now holds 4,062,377 shares worth roughly $41.64 million.
Then, Anzalone Christopher Richard bought 51,425 shares, generating $774,785 in total proceeds.
Before that, Anzalone Christopher Richard sold 166,667 shares. Arrowhead Pharmaceuticals Inc shares valued at $3,005,006 were divested by the Chief Executive Officer at a price of $18.03 per share. As a result of the transaction, Anzalone Christopher Richard now holds 3,907,135 shares, worth roughly $40.05 million.
Goldman initiated its Arrowhead Pharmaceuticals Inc [ARWR] rating to a Neutral in a research note published on June 05, 2024; the price target was $31. A number of analysts have revised their coverage, including BofA Securities’s analysts, who began to cover the stock in early December with a ‘”a Buy”‘ rating. Citigroup began covering ARWR with “Neutral” recommendation on September 19, 2023. TD Cowen started covering the stock on July 21, 2023. It rated ARWR as “an Outperform”.
Price Performance Review of ARWR
On Monday, Arrowhead Pharmaceuticals Inc [NASDAQ:ARWR] saw its stock fall -4.03% to $10.25. Over the last five days, the stock has lost -19.54%. Arrowhead Pharmaceuticals Inc shares have fallen nearly -45.48% since the year began. Nevertheless, the stocks have fallen -60.74% over the past one year. While a 52-week high of $30.41 was reached on 02/07/25, a 52-week low of $10.65 was recorded on 04/07/25. SMA at 50 days reached $17.12, while 200 days put it at $21.05.
Levels Of Support And Resistance For ARWR Stock
The 24-hour chart illustrates a support level at 9.52, which if violated will result in even more drops to 8.80. On the upside, there is a resistance level at 11.02. A further resistance level may holdings at 11.80. The Relative Strength Index (RSI) on the 14-day chart is 21.93, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.42, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.94%. Stochastics %K at 7.45% indicates the stock is a buying.
How much short interest is there in Arrowhead Pharmaceuticals Inc?
A steep rise in short interest was recorded in Arrowhead Pharmaceuticals Inc stocks on 2025-03-14, growing by 1.01 million shares to a total of 10.44 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 9.43 million shares. There was a rise of 9.66%, which implies that there is a positive sentiment for the stock.
